Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants
Articles > Article · 2005
Authors: DAVİD FİTZSİMONS, GUİDO FRANÇOİS, ANDREW HALL, BRİAN MCMAHON, ANDRÉ MEHEUS, ALESSANDRO ZANETTİ, BERNARD DUVAL, WOLFGANG JİLG, WULF OTTO BÖCHER, SN Lu, Ulus Salih AKARCA, DANİEL LAVANCHY, SUSAN GOLDSTEİN, JANGU BANATVALA, P Van Damme
Vaccine, Journal Indexed in SCI Expanded, International, WoS, 2005, vol 23, pp 4158-4166
DOI: 10.1016/j.vaccine.2005.03.017
Summary
The long-term efficacy of hepatitis B vaccine, long-term effectiveness of hepatitis B immunisation programmes, immune memory induced by hepatitis B vaccine, current booster policies, and impact of hepatitis B virus mutants on immunisation programmes were reviewed at the Viral Hepatitis Prevention Board (VHPB) meeting in Sevilla, Spain, March 2004. The main focus was on universal vaccination programmes with data being presented from Italy, Saudi Arabia, Singapore, Spain, Taiwan, Thailand, The Gambia, and USA (Alaska). (c) 2005 Elsevier Ltd. All rights reserved.